On 15 january 2020, (b)(6) from (b)(6) called anika to report that she was experiencing possible allergic reaction to an orthovisc injection and it was provoked in her knee.The same reports was received from this patient through the fda medwatch report mw5092019.On 29 january 2020, patient provided additional information on this case.Patient reported having the orhovisc treatment on (b)(6) 2019 and on (b)(6), experience allergic reaction (hives and rashes over entire body, swelling of feet, knees, and calves, and toes with clear liquid).Patient reported refusing the third injection due to these allergic reactions.Patient reported she had in the past used supartz treatment every six months for several decades because she no longer have meniscus in either knee.Patient reported never experiencing allergic reaction after supartz treatment.
|